Modification of BRCA1-associated breast cancer risk by HMMR overexpressionFrancesca Mateo, Miguel Ángel Pujana, Luís Palomero et al.|Nature Communications|2022Cited by 53
Histamine signaling and metabolism identify potential biomarkers and therapies for lymphangioleiomyomatosisCarmen Herranz, Aslihan Ugun‐Klusek, Francesca Mateo et al.|EMBO Molecular Medicine|2021Cited by 21
Lymphangioleiomyomatosis Biomarkers Linked to Lung Metastatic Potential and Cell StemnessGorka Ruíz de Garibay, Miguel Ángel Pujana, Carmen Herranz et al.|PLoS ONE|2015Cited by 20
Immune Cell Associations with Cancer RiskLuís Palomero, Miguel Ángel Pujana, Iván Galván‐Femenía et al.|iScience|2020Cited by 14
Altered regulation of <i>BRCA1</i> exon 11 splicing is associated with breast cancer risk in carriers of <i>BRCA1</i> pathogenic variantsGorka Ruíz de Garibay, Miguel Ángel Pujana, Ignacio Fernandez‐Garcia et al.|Human Mutation|2021Cited by 12